Regulation & Policy

Getty Images

Guest article

CBD, climate crisis, sustainability: ABC takes a look at 2019 and beyond

By Stefan Gafner and Mark Blumenthal, American Botanical Council

The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.

Getty Images

Guest article

The legacy of 2019: CBD, mandatory listing and discord

By Steve Mister, President & CEO, Council for Responsible Nutrition

The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.

Getty Images

News in brief

Kaneka gets GRAS status on baby probiotic

By Hank Schultz

Kaneka has announced self affirmed GRAS status on its Baby Colic probiotic dietary supplement meant to ease babies through gut discomfort episodes.

©iStock/

EDITOR'S SPOTLIGHT: SCIENCE & REGULATION

CBDepot files Novel Food application for synthetic CBD form

By Will Chu

CBDepot has applied for Novel Food (NF) application for a synthetic form of cannabidiol (CBD) for food supplement use in a move the firm says has a better chance of regulatory approval.

© Getty Images / Olga Volkovaia

Guest article

NPA review of 2019: CBD Goes Mainstream

By Daniel Fabricant, PhD, CEO and President of the Natural Products Association (NPA)

2019 will be remembered as the year Cannabidiol (CBD) hit the American mainstream. From Ben and Jerry’s Ice Cream to pet food and hand lotions to vape pens, CBD is everywhere we look. Which is why it is easy to understand why the majority of Americans...

Follow us

Featured Events

View more

Products

View more

Webinars